Purpose: To assess the impact of 2005 and 2006 reductions in chemotherapy
reimbursement, mandated in the Medicare Modernization Act, on patterns of chemotherapy …

Purpose: This study tested the combination of an episode payment coupled with actionable
use and quality data as an incentive to improve quality and reduce costs. Methods: Medical …

More-sophisticated chemotherapy regimens have improved the outlook for cancer patients
since the 1970s, but the payment system for cancer chemotherapy has not changed during …

Purpose: The Oncology Care Model (OCM) is a highly controversial specialty care model
developed by the Centers for Medicare & Medicaid aimed to provide higher-quality care at …

With unsustainable and rising health care costs reaching what are regularly termed crisis
levels, the United States' current fragmented and inefficient health care system is in need of …

Treating patients with cancer with infused or injected oncolytics is a core component of
outpatient oncology practice. Currently, practices purchase drugs and then bill insurers …

Purpose The cost of cancer care continues to increase at an unprecedented rate. Concerns
have been raised about financial incentives associated with the chemotherapy concession …

Infusion of chemotherapy has long been a profit center for medical oncologists. Under the
current system, oncologists purchase cancer drugs at one price, then bill insurers at a higher …

The Medicare Prescription Drug, Improvement, and Modernization Act, enacted in 2003,
substantially reduced payment rates for chemotherapy drugs administered on an outpatient …

In recent years many policy makers have recommended alternative payment models in
medical oncology in order to reduce costs and improve patient outcomes. Yet information on …